HIV/AIDS Prevention Trials Capacity Building Grants - Phase II

Canada's international response to the HIV/AIDS epidemic is largely built around the work of the Canadian HIV Vaccine Initiative (CHVI). CHVI proposes to increase the capacity of Canada and low- and middle-income countries to respond to the HIV/AIDS pandemic by developing new HIV vaccines and other preventive approaches; investigating social and policy issues related to HIV/AIDS; conducting clinical trials; and building an HIV vaccine manufacturing facility in Canada. The third component, conducting clinical trials, requires the participation of research institutions from around the world, including those operating in high HIV-prevalence countries. However, such institutions - especially those in Africa - often lack the necessary research capacity to fully engage in clinical trials. In order to address this challenge, the Canadian International Development Agency (CIDA) has allocated CA$ 6 million to the Global Health Research Initiative (GHRI) to support building African capacity for clinical trials.

This project will build on work carried out under an earlier effort, Capacity Building for HIV/AIDS Prevention Trials (104051).

Project ID


Project status


Start Date

Monday, June 1, 2009

End Date

Tuesday, March 31, 2015


56 months

IDRC Officer

Mhatre, Sharmila

Total funding

CA$ 1,265,640


North of Sahara, South of Sahara, Canada


Maternal and Child Health